AYX Stock Recent News
AYX LATEST HEADLINES
Alteryx, Inc. (AYX) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to loss of $0.46 per share a year ago.
Machine learning (ML) is a branch of artificial intelligence (AI) that enables computers to learn from data and experience without explicit programming. The potential of language-based AI, as exhibited through innovative breakthroughs such as OpenAI's ChatGPT, has made machine learning stocks among the hottest investments in 2023.
The Nasdaq 100 surprised many investors in 2023 with a strong rally. The index is up by roughly 45% year-to-date as the Magnificent Seven continue to surge higher.
Alteryx (AYX) to offer intelligent automation on AWS for finance teams to modernize processes and adopt new technology. This reflects on its strong product portfolio and partner base.
Alteryx (AYX) extends its partnership with Databricks by launching new technical capabilities to drive productivity, suggesting a strong partner base and an innovative portfolio.
Alteryx has a solid revenue growth profile, but the company still did not achieve sustainably positive free cash flow. The stock looks attractively valued, but the level of uncertainty regarding underlying assumptions is very high. I add the stock to my short-list, but before I invest, I want to examine how the next few quarters will develop.
Start Time: 11:00 January 1, 0000 11:42 AM ET Alteryx, Inc. (NYSE:AYX ) Rosenblatt Securities Technology Summit: The Age of AI June 08, 2023, 11:00 AM ET Company Participants Kevin Rubin - CFO Suresh Vittal - Chief Product Officer Conference Call Participants Blair Abernethy - Rosenblatt Securities Blair Abernethy Good morning, everyone. It's Blair Abernethy, software analyst with Rosenblatt back again here this time with Alteryx.
IRVINE, Calif. , May 30, 2023 /PRNewswire/ -- Alteryx, Inc. (NYSE: AYX), the Analytics Cloud Platform company, today announced that it will participate in the following upcoming investor conferences: TD Cowen Technology, Media & Telecom Conference on May 31 at 11:00 a.m.
Alteryx is unlocking the power of data analytics for thousands of businesses. CRISPR Therapeutics is developing innovative treatments for serious diseases.
Over the past few years Alteryx has built out an end-to-end machine learning platform and developed a cloud solution. Generative AI could be supportive of Alteryx's focus on citizen data scientists, but the same capabilities are available to all vendors.